world

Blockbuster retatrutide trial signals a ‘new high-water mark’ for weight-loss drugs

Scientific American

September 29, 2026

via Scientific American

You're reading one story from Newsaly

Newsaly brings together 60,000+ newspaper articles, 30,000+ podcasts and 10,000+ magazine articles from around the world.

A World Of News, One Window.

<p>The experimental weight-loss drug is a triple agonist and the first of its kind to reach a phase 3 clinical trial</p>

Read the full story

Explore newspapers from around the world.

Discover podcasts and listen to the latest conversations and news.

Explore magazine articles from around the world.

Share a 15-second voice reaction. Voices automatically disappear after 10 days.

Be the first to share a voice on this article.